Moreover, the obtained renal beneficial effects of RGZ were independent of enhanced generation of the second messenger cGMP in response to ANP, which was found largely unaltered both in vivo and in vitro, in CHF as well as in control rats. The gene discussed is NPPA; the disease is congestive heart failure.